Uplizna 100 mg/10ml, Konzentrat zur Herstellung einer Infusionslösung
7680693220010
CH-69322
Konzentrat
Associated product:
UPLIZNA conc perf 100 mg/10ml 3 flac 10 ml
1 / 3
google
Article details
- Package size
- 3
- Selling units
- 3
- Measure
- Durchstechflasche(n)
- Galenic form
- Konzentrat
- Galenic group
- Tinkturen/Desinfektion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
100.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
16.1 MG | Substance | HBESI |
Authorization holder
Amgen Switzerland AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 69322
- Drug name
- Uplizna, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- L04AA47
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 04/03/2024
- Authorization expiration date
- 03/03/2029
- IT Number
- 07.15.0.
- Domain
- Human medicine
Package details
- Description (FR)
- UPLIZNA conc perf 100 mg/10ml 3 flac 10 ml
- Description (DE)
- UPLIZNA Inf Konz 100 mg/10ml 3 Durchstf 10 ml
- Market launch
- 04/03/2024
- Narcotic (BTM)
- No